Planned, subject to FDA approval
RESTORE-HF study design
The pilot study of the UPright™ System.
Prospective, randomized, sham-controlled, double-blind pilot study.
Procedures are planned at sites in the United States and Europe.
Further details will be published after FDA approval.
US Steering Committee
Leaders in heart failure, exercise hemodynamics and interventional cardiology guide our US clinical program.
For investigators
Interested in taking part?
We welcome inquiries from heart failure and interventional cardiology teams in the United States and Europe. Details will be published after FDA approval.